Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00033005
DRKS00033005
Recruiting
Phase 4

Clinical effects of treatment of complex regional pain syndrome (CRPS) with pulsed electromagnetic fields (PEMF): a double-blind randomized controlled pilot study - PEMF in CRPS

niversitätsklinikum Schleswig-Holstein, Campus Kiel0 sites50 target enrollmentNovember 9, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG90.5G90.6G90.7Complex regional pain syndrome type IComplex regional pain syndrome type IIComplex regional pain syndrome, other and unspecified type

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
G90.5
Sponsor
niversitätsklinikum Schleswig-Holstein, Campus Kiel
Enrollment
50
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2023
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversitätsklinikum Schleswig-Holstein, Campus Kiel

Eligibility Criteria

Inclusion Criteria

  • •CRPS of the upper and/or lower extremity reliably diagnosed according to Budapest criteria (differential diagnoses are excluded)

Exclusion Criteria

  • •Change in therapy in the last 3 weeks before inclusion in the study or cortisone therapy within the last four weeks before inclusion
  • •\- Patients who are not capable of giving informed consent themselves
  • •\- Patients who are physically or mentally incapable of using the device independently
  • •\- Patients with cognitive deficits or limited knowledge of the German language, which may lead to difficulties in data collection
  • •\- Patients with pacemakers, defibrillators or other active implants
  • •\- Patients with magnetic implants (non\-MRI compatible implants)
  • •\- Patients receiving corticosteroid injections
  • •\- Patients with severe infections, polyneuropathy or other neurological diseases that can affect sensory or motor function and that cannot be differentiated from CRPS by the patient
  • •\- Patients who are pregnant or breastfeeding
  • •\- Patients with tumor diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Impact of comprehensive and intensive treatment of risk factors concerning cardiovascular mortality in secondary prevention: MIRVAS studySecondary prevention of cardiovascular diseaseCirculatory System
ISRCTN93700442a Princesa University Hospital (Hospital Universitario de La Princesa) (Spain)247
Withdrawn
Phase 4
Treatment of Complex Regional Pain Syndrome type I;A randomised, double-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions (The Ket Ket Study)
NL-OMON31841eids Universitair Medisch Centrum30
Active, not recruiting
Not Applicable
Treatment of Complex Regional Pain Syndrome type I: A randomised, double-blind, placebo-controlled study with multiple rounds of S(+)-ketamine infusions - KetKetStudyChronic CRPS ian
EUCTR2008-003693-17-NLeiden University Medical Center30
Completed
Not Applicable
Clinical and radiographic results of treatment of periodontal intrabony defects with porous titanium granules and xenograft with collagen membranemoderate to severe chronic periodontitis.B99
IRCT2015111425042N1vice chancellor for Research of Dental School ,Shahid Beheshti University of Medical Science15
Completed
Not Applicable
Mirror therapy in patients with complex regional pain syndrome type one of the upper extremity: a randomised clinical trial
ISRCTN68438240Erasmus Medical Centre (The Netherlands)52